Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-188.09%
operating margin TTM
-159.5%
revenue TTM
73.30 Million
revenue per share TTM
0.74$
valuation ratios | |
|---|---|
| pe ratio | -6.01 |
| peg ratio | 0.61 |
| price to book ratio | -14.96 |
| price to sales ratio | 9.21 |
| enterprise value multiple | -6.19 |
| price fair value | -14.96 |
profitability ratios | |
|---|---|
| gross profit margin | 58.35% |
| operating profit margin | -159.5% |
| pretax profit margin | -188.09% |
| net profit margin | -188.09% |
| return on assets | -52.23% |
| return on equity | 195.65% |
| return on capital employed | -62.98% |
liquidity ratios | |
|---|---|
| current ratio | 3.14 |
| quick ratio | 3.01 |
| cash ratio | 2.55 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 121.35 |
| operating cycle | 266.90 |
| days of payables outstanding | 587.42 |
| cash conversion cycle | -320.52 |
| receivables turnover | 2.51 |
| payables turnover | 0.62 |
| inventory turnover | 3.01 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.82 |
| debt equity ratio | -3.90 |
| long term debt to capitalization | 1.41 |
| total debt to capitalization | 1.34 |
| interest coverage | -4.16 |
| cash flow to debt ratio | -0.40 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.43 |
| cash per share | 0.99 |
| operating cash flow per share | -0.43 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -0.40 |
| short term coverage ratios | -4.51 |
| capital expenditure coverage ratio | -93.30 |
Frequently Asked Questions
When was the last time Aquestive Therapeutics, Inc. (NASDAQ:AQST) reported earnings?
Aquestive Therapeutics, Inc. (AQST) published its most recent earnings results on 05-11-2025.
What is Aquestive Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Aquestive Therapeutics, Inc. (NASDAQ:AQST)'s trailing twelve months ROE is 195.65%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Aquestive Therapeutics, Inc. (AQST) currently has a ROA of -52.23%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AQST's net profit margin stand at?
AQST reported a profit margin of -188.09% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AQST's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.14 in the most recent quarter. The quick ratio stood at 3.01, with a Debt/Eq ratio of -3.90.